173 related articles for article (PubMed ID: 20628041)
1. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
[TBL] [Abstract][Full Text] [Related]
2. Interaction between levodopa and enteral nutrition.
Cooper MK; Brock DG; McDaniel CM
Ann Pharmacother; 2008 Mar; 42(3):439-42. PubMed ID: 18272698
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome without neuroleptics.
Parsa MA; Rohr T; Ramirez LF; Meltzer HY
J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
[No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome without neuroleptics.
Ong KC; Chew EL; Ong YY
Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome in advanced Parkinson's disease.
Gordon PH; Frucht SJ
Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
[TBL] [Abstract][Full Text] [Related]
6. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
7. [A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
Kumagai R; Harada T; Kurokawa K; Okazaki M; Egi N; Shimote K; Nakamura S
No To Shinkei; 1998 Aug; 50(8):745-9. PubMed ID: 9757468
[TBL] [Abstract][Full Text] [Related]
8. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant-like syndrome: case report.
Tibbels CK; Seegers S
Tex Med; 1988 May; 84(5):40-3. PubMed ID: 3406898
[No Abstract] [Full Text] [Related]
10. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
11. Postoperative hyperthermic syndrome following antiparkinsonian drugs withdrawal: the pitfall of enteral refeeding.
Casier I; Jeanjean A; Hantson P
Anaesth Intensive Care; 2013 Nov; 41(6):814-5. PubMed ID: 24180734
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Ward C
J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
[TBL] [Abstract][Full Text] [Related]
13. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report.
Fiore S; Persichino L; Anticoli S; De Pandis MF
Acta Biomed; 2014 Dec; 85(3):281-4. PubMed ID: 25567468
[TBL] [Abstract][Full Text] [Related]
14. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
Ladha SS; Walker R; Shill HA
Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
[TBL] [Abstract][Full Text] [Related]
15. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
Friedman JH; Feinberg SS; Feldman RG
JAMA; 1985 Nov; 254(19):2792-5. PubMed ID: 4057489
[TBL] [Abstract][Full Text] [Related]
16. Levodopa Withdrawal Presenting as Fever in a Critically Ill Patient Receiving Concomitant Enteral Nutrition.
Whitman CB; Ablordeppey E; Taylor B
J Pharm Pract; 2016 Dec; 29(6):574-578. PubMed ID: 26801658
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
Keyser DL; Rodnitzky RL
Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
[TBL] [Abstract][Full Text] [Related]
18. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
Facca A; Sanchez-Ramos J
Mov Disord; 1996 May; 11(3):327-9. PubMed ID: 8723153
[No Abstract] [Full Text] [Related]
19. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
Gerschlager W; Bloem BR
Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
[No Abstract] [Full Text] [Related]
20. First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy.
Djaldetti R; Achiron A; Ziv I; Melamed E
Mov Disord; 1994 Sep; 9(5):582-3. PubMed ID: 7990855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
